Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  EnteroMedics Inc    ETRM   US29365M2089

ENTEROMEDICS INC (ETRM)

11
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/16/2014 04/17/2014 04/21/2014 04/22/2014 04/23/2014 Date
1.635(c) 1.67(c) 1.82(c) 1.81(c) 1.82 Last
583 764 502 089 1 053 293 1 722 448 13 469 Volume
+4.81% +2.14% +8.98% -0.55% +0.55% Change
More quotes
Company
EnteroMedics, Inc. is a clinical development stage medical device company with approvals to commercially launch its product in Australia and the European Economic Area. It's focused on the designs and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and... 
Surperformance© rating of EnteroMedics Inc
Trading Rating : Investor Rating :
More about the company
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1,64 M
EBIT 2014 -24,9 M
Net income 2014 -25,6 M
Debt 2014 27,1 M
Yield 2014 -
Sales 2015 23,4 M
EBIT 2015 -21,5 M
Net income 2015 -22,2 M
Debt 2015 12,6 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 91,0x
EV / Sales 2015 5,75x
Capitalization 122 M
More Financials
Latest news on ENTEROMEDICS INC
04/09 ENTEROMEDICS : Appoints Mark Bullivant as Vice President of Marketing
03/10 EnteroMedics Announces the FDA Has Rescheduled the Advisory Committee Meeting..
02/25 EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conf..
02/12 ENTEROMEDICS INC : FILES (8-K) Disclosing Results of Operations and Financial Co..
02/12 EnteroMedics Reports Fourth Quarter 2013 Financial Results
02/12 EnteroMedics Announces Food and Drug Administration Advisory Committee Meetin..
01/08 ENTEROMEDICS INC : Patent Issued for Pancreatic Exocrine Secretion Diversion App..
01/07 ENTEROMEDICS INC : EnteroMedics Assigned Patent
2013 ENTEROMEDICS INC : EnteroMedics Announces 18 Month ReCharge Study Results
2013 EnteroMedics Announces 18 Month ReCharge Study Results
2013 ENTEROMEDICS INC : EnteroMedics to Participate in Fireside Chat at the Canaccord..
2013 ENTEROMEDICS INC : EnteroMedics Reports Third Quarter 2013 Financial Results
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
EnteroMedics Inc : Income Statement Evolution
More Financials
EPS Revisions
EnteroMedics Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF